This consultation provides an opportunity to review medication dosing, assess adherence, identify potential barriers, and consider whether additional investigations or interventions are warranted
Tirzepatide is a once-weekly injectable medication approved for type 2 diabetes and chronic weight management, offering patients flexibility in administration timing
Warner GJ, Berry MJ, Moustafa ME, Carlson BA, Hatfield DL, Faust JR
Pontifcia Universidade Catlica de Campinas, v
First, it provides a comprehensive investigation of the associations between GLP-1RAs and 12 common psychiatric and neurodevelopmental conditions, utilizing large-scale GWAS summary statistics